InnoCan Pharma Corporation (CSE:INNO)

InnoCan Pharma Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	112	60	83	54	199	62
Market Cap Growth	81.13%	-27.47%	54.74%	-72.99%	218.14%	171.46%
Enterprise Value	107	56	78	45	191	60
Last Close Price	18.50	13.65	20.15	13.97	52.00	21.77
PS Ratio	2.84	1.42	4.61	15.50	801.47	6129.83
PB Ratio	12.24	5.96	14.34	6.37	17.43	-13.59
P/TBV Ratio	19.47	8.11	15.33	6.20	17.35	-
EV/Sales Ratio	2.72	1.32	4.32	12.89	771.51	5897.57
Debt / Equity Ratio	0.21	0.00	0.01	0.01	0	-0.01
Asset Turnover	2.92	3.63	1.96	0.26	0.02	0.00
Inventory Turnover	1.26	1.28	1.17	0.55	0.16	-
Quick Ratio	2.70	2.48	1.79	7.10	3.15	0.44
Current Ratio	3.70	4.09	2.68	9.41	3.51	0.54
Return on Equity (ROE)	-4.84%	-4.59%	-80.07%	-51.05%	-373.46%	-
Return on Assets (ROA)	2.01%	-9.62%	-34.16%	-40.06%	-55.30%	-85.40%
Return on Capital (ROIC)	2.81%	-13.61%	-44.52%	-51.29%	-171.78%	-
Earnings Yield	-1.92%	-4.38%	-7.47%	-9.49%	-6.40%	-20.30%
FCF Yield	-0.57%	-3.81%	-6.28%	-15.36%	-4.25%	-7.52%
Buyback Yield / Dilution	-7.00%	-8.96%	-3.23%	-10.87%	-38.59%	-34.30%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.